🇺🇸·13h agoIndustry
United Therapeutics Corporation Presents New Data from TETON-1, ADVANCE OUTCOMES, and Additional Research in Pulmonary Hypertension and Pulmonary Fibrosis at ATS 2026
Publisher
U
United Therapeutics (IR)
USA
This page provides a limited summary and publisher metadata to support discovery before sending readers to the original article.
Read originalIn-platform summary, original article off-platform
This page presents the title, publisher metadata, and a limited summary excerpt to help users judge relevance first. Full-text reading stays on the publisher's original site.
Source route
Continue on ir.unither.com
Leave the platform to read the original full article on the publisher site.
Source: United Therapeutics (IR)
Scope: Industry
Related coverage
More related coverage
WuXi Biologics·7h ago
Navigating the Complexity of Bispecific/Multispecific Antibodies from R&D to Manufacturing – Accelerating the Path from Lab to Patient
WuXi Biologics·11h ago
ED/VP Commercial CMC Europe
WuXi Biologics·11h ago
ED/VP Commercial CMC North America
WuXi Biologics·11h ago